Visit our reviews page to see a complete list of reviews in the prostate cell research field.
New Anti-Cancer Stem Cell Compound in Development
Scientists have developed a novel anti-cancer stem cell agent capable of targeting aggressive tumor forming cells common to breast, pancreas, colon and prostate cancers. The new OH14 compound has been licensed by Tiziana Life Sciences, a British-based pharmaceutical company. [Cardiff University] Press Release
UB Spinoff Gets $2 Million for Research on Cancer Therapy
For-Robin, a University at Buffalo (UB) spinoff company, has received a $2 million grant from the National Cancer Institute to study and develop a promising potential treatment for breast and other types of cancer, UB and U.S. Congressman Brian Higgins have announced. [University of Buffalo] Press Release